Atossa Therapeutics Inc. Overview

Atossa Therapeutics, Inc., a biopharmaceutical company based in Seattle, Washington, is dedicated to discovering proprietary therapeutics and delivery methods for breast cancer and related conditions. Operating globally, the company focuses on providing innovative solutions to address unmet patient needs in the health care sector, particularly in oncology.

Recent Financial Performance

As of July 1, 2025, Atossa Therapeutics Inc. reported a close price of $0.84 on the Nasdaq exchange. This figure reflects a significant fluctuation over the past year, with the company’s stock reaching a 52-week high of $1.66 on November 10, 2024, and a 52-week low of $0.55 on April 6, 2025.

Industry and Sector

Atossa Therapeutics operates within the Health Care sector, specifically under the Health Care Equipment & Supplies industry. The company’s focus on oncology and breast cancer treatment positions it as a key player in the biopharmaceutical landscape, aiming to innovate and improve therapeutic options for patients.

Global Operations

With its headquarters in Seattle, Atossa Therapeutics extends its operations globally, striving to meet the diverse needs of patients worldwide. The company’s commitment to innovation and patient care underscores its role in advancing treatment options in the field of oncology.

Conclusion

Atossa Therapeutics Inc. continues to navigate the challenges and opportunities within the biopharmaceutical industry, focusing on the development of novel therapeutics for breast cancer and related conditions. Despite recent stock price volatility, the company remains dedicated to its mission of addressing unmet patient needs through innovative solutions.